The U.S. egg freezing and embryo banking market is expected to experience significant growth in the coming years due to increasing awareness about fertility preservation options among women. The market is also being driven by the growing trend of delaying childbirth for career advancement, as well as advancements in assisted reproductive technology.
Two growth drivers for the U.S. egg freezing and embryo banking market are the increasing number of women opting for elective egg freezing to preserve their fertility, and the rising demand for donor eggs and embryos from same-sex couples and single individuals looking to build their families.
On the other hand, two industry restraints for the market include the high cost of egg freezing and embryo banking procedures, which can be prohibitive for many individuals, as well as the lack of insurance coverage for these services, making them inaccessible to a large portion of the population.
Segment Analysis:
The U.S. egg freezing and embryo banking market can be segmented by service type, end user, and region. The main service types include egg freezing and embryo banking, with the majority of revenue coming from egg freezing services. End users of these services include fertility clinics, hospitals, and surgical centers. The market is also segmented by region, with the highest demand for these services being seen in urban areas with higher concentrations of young professional women.
Competitive Landscape:
The U.S. egg freezing and embryo banking market is highly competitive, with key players such as Extend Fertility, Prelude Fertility, and OvaScience dominating the market. These companies offer a range of services including egg freezing, embryo banking, and fertility consultations. In order to stay competitive, companies in this market must continue to innovate in terms of technology and service offerings, as well as expand their market reach to attract a larger customer base.